https://cvent.me/Y1vam0 ANCO and MOASC are collaborating on a Precision Oncology Symposium on November 5 at the InterContinental Hotel in San Francisco. Precision oncology promises to improve the outcomes of patients through broad molecular diagnostic profiling and individualized treatment recommendations. Recent FDA approvals of new cancer treatments that are based on molecular tumor features and not disease type underscore the...

The faculty will present the latest research on treatment modalities for hematologic malignancies—leukemias, lymphomas, and myeloma—along with case studies for these diagnoses. The program takes place in San Francisco on November 12th Registration and continental breakfast will be available at 8:00 am; presentations begin at 9 am. The program will conclude by 12:30pm. ANCO acknowledges...

As new clinical data continues to emerge as a result of ongoing research in breast cancer diagnostics and therapeutics, official Best of SABCS® programs cover these important developments in each of the live, regional events. Each regional event provides an educational forum for local researchers and clinicians to discuss the most pertinent basic, translational, and...

THIS EVENT IS NOT SPONSORED OR PLANNED BY ANCO Date & Location Saturday, February 11, 2023, 8:00 AM - 4:00 PM PST, Ritz-Carlton, Half-Moon Bay, CA Overview The Steven Coutre Review of the 64th Annual American Society of Hematology Meeting will highlight cutting-edge research and data on hematologic disorders as well as provide participants with updated...

This conference will present the most current information on multidisciplinary approaches in clinical oncology and will consist of tumor board cases on breast, , gastrointestinal, genitourinary,  hematologic malignancies, lymphoma, and thoracic cancers. The tumor board cases will be presented by faculty, with discussion by a panel of surgical, radiation, and medical oncologists from Stanford, UC...

ANCO's Hematologic Malignancies Update 2023 will take place May 6th & 7th at the Hyatt Regency Monterey Bay, The faculty will present the latest research on treatment modalities for hematologic malignancies—leukemias, lymphomas, and myeloma—along with case studies for these diagnoses. Program Information and Registration: https://cvent.me/mPEbny Make your hotel reservation now! https://www.hyatt.com/en-US/group-booking/MRYDM/G-HEMA

 Join Stanford Medicine Cancer Center for a special live, online discussion about body image and intimacy after cancer.    LIVE WEBINAR FEATURING: Discussion of self-image, vulvar-vaginal health, intimacy, and sexual symptoms after cancer treatment Counseling and education on treatment plans for vaginal dryness, low libido, psychosocial difficulties surrounding intimacy, and other symptoms  Input from cancer...

The 24th Annual International Lung Cancer Congress® will distill the latest data on targeted agents, immunotherapy, surgery, and radiation oncology for the management of lung cancer. As in previous years, we will also preview novel agents and strategies with the potential to shape the future of lung cancer therapy. Cutting-edge lectures, extended panel discussions, multidisciplinary tumor boards, and...

ANCO’s ASCO23 Highlights will summarize the major research and treatment advancements presented at this year’s ASCO23 Meeting. The program will focus on breast, gastrointestinal, genitourinary, gynecologic, hematologic malignancies, lung cancers, and sarcoma, as well as a plenary session on Equity: Every Patient. Every Day. Everywhere, in addition to a panel on equity. The faculty will...

 Join us for our inaugural Health Equity Research Summit on Saturday, September 9, 2023. We will have multidisciplinary presentations and discussions regarding health equity and oncology. Discussions on evidence-based approaches to advancing health equity in oncology with experts with unique research, community, and policy perspectives.   Registration is now open! Register here